当前位置:首页 - 行情中心 - 微电生理-U(688351) - 财务分析

微电生理-U

(688351)

  

流通市值:26.73亿  总市值:100.76亿
流通股本:1.25亿   总股本:4.71亿

微电生理-U(688351)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.42亿元,每股收益0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益173072.34万元,未分配利润-755.00万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产186810.82万元,负债13738.48万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入290,866,132.55198,364,587.4489,152,510.16329,194,871.27
营业总成本287,957,417.1194,365,348.2689,554,495.9357,813,965.77
营业利润43,955,481.1519,270,135.516,181,921.577,646,094.41
利润总额41,741,739.5617,032,732.924,169,185.755,610,357.38
净利润41,726,652.817,012,670.684,169,185.755,688,512.88
其他综合收益522.72---
综合收益总额41,727,175.5217,012,670.684,169,185.755,688,512.88
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,572,753,795.811,552,294,967.941,544,532,039.551,519,229,127.83
非流动资产合计295,354,355.91299,089,456.14298,928,544.73304,039,258.27
资产总计1,868,108,151.721,851,384,424.081,843,460,584.281,823,268,386.1
流动负债合计104,389,405.3109,257,881.4114,012,195.1696,435,469.96
非流动负债合计32,995,370.8437,316,003.4638,581,071.9841,774,873.2
负债合计137,384,776.14146,573,884.86152,593,267.14138,210,343.16
归属于母公司股东权益合计1,730,723,375.581,704,810,539.221,690,867,317.141,685,058,042.94
股东权益合计1,730,723,375.581,704,810,539.221,690,867,317.141,685,058,042.94
负债和股东权益合计1,868,108,151.721,851,384,424.081,843,460,584.281,823,268,386.1
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计364,595,784.66233,248,637.1896,586,955.28361,632,850.46
经营活动现金流出小计302,621,144.71195,327,184.790,325,985.28399,603,995.44
经营活动产生的现金流量净额61,974,639.9537,921,452.486,260,970-37,971,144.98
投资活动现金流入小计3,380,961,011.942,370,587,539.681,069,080,977.53,515,210,943.86
投资活动现金流出小计3,457,615,188.182,124,271,636.99939,341,708.993,789,868,605.31
投资活动产生的现金流量净额-76,654,176.24246,315,902.69129,739,268.51-274,657,661.45
筹资活动现金流入小计----
筹资活动现金流出小计8,111,077.15,454,209.92,414,583.210,468,617.43
筹资活动产生的现金流量净额-8,111,077.1-5,454,209.9-2,414,583.2-10,468,617.43
汇率变动对现金及现金等价物的影响-604,635.22-11,722.48-102,461.94505,352.61
现金及现金等价物净增加额-23,395,248.61278,771,422.79133,483,193.37-322,592,071.25
期末现金及现金等价物余额232,503,279.03534,669,950.43389,381,721.01255,898,527.64
最新报告期:2024-10-30
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
东方财富证券何玮0.080.150.262024-10-30
广发证券罗佳荣0.090.130.182024-10-22
中金公司俞波0.070.14--2024-10-22
华泰证券代雯,高鹏0.070.150.242024-10-21
中信证券宋硕,陈竹0.050.120.232024-09-13
TOP↑